Viatris (VTRS) Other financing activities (2019 - 2026)
Viatris (VTRS) recorded quarterly Other financing activities of -$300000.0 in Q1 2026, up 99.84% quarter-over-quarter from -$191.4 million in Q4 2025, and up 99.73% on a YoY basis from -$150205.6 in Q1 2025.
Viatris (VTRS) Other financing activities (2019 - 2026) Analysis & Trends
Viatris' Other financing activities history runs 8 years deep, the most recent figure standing at -$300000.0 for Q1 2026.
- In Q1 2026, Other financing activities rose 99.73% year-over-year to -$300000.0; the TTM figure through Mar 2026 stood at -$80.8 million (down 145.04% YoY), while the FY2025 annual figure was -$190.1 million, down 164.4% from the prior year.
- Other financing activities was -$300000.0 for Q1 2026 at Viatris, up from -$191.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $290.4 million in Q4 2024 to a low of -$277.2 million in Q4 2023.
- Historically, Other financing activities has averaged -$3.1 million across 5 years, with a median of $4.0 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Other financing activities surged 6000.0% in 2023, then slumped 1867.74% in 2025.
- A 5-year view of Other financing activities shows it stood at $17.0 million in 2022, then tumbled by 1730.59% to -$277.2 million in 2023, then jumped by 204.76% to $290.4 million in 2024, then slumped by 165.91% to -$191.4 million in 2025, then jumped by 99.84% to -$300000.0 in 2026.
- The last three Other financing activities figures came in at -$300000.0 (Q1 2026), -$191.4 million (Q4 2025), and $156.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -300,000.00 |
| Mar 31, 2026 | -300,000.00 |
| Dec 31, 2025 | -191.40 Mn |
| Dec 31, 2025 | -191.40 Mn |
| Sep 30, 2025 | 156.30 Mn |
| Sep 30, 2025 | 156.30 Mn |
| Jun 30, 2025 | -45.40 Mn |
| Jun 30, 2025 | -45.40 Mn |
| Mar 31, 2025 | -109.60 Mn |
| Mar 31, 2025 | -109.60 Mn |
| Dec 31, 2024 | 290.40 Mn |
| Dec 31, 2024 | 290.40 Mn |
| Sep 30, 2024 | -124.00 Mn |
| Sep 30, 2024 | -124.00 Mn |
| Jun 30, 2024 | 122.60 Mn |
| Jun 30, 2024 | 122.60 Mn |
| Mar 31, 2024 | 6.20 Mn |
| Mar 31, 2024 | 6.20 Mn |
| Dec 31, 2023 | -277.20 Mn |
| Dec 31, 2023 | -277.20 Mn |